Each specimen is carefully profiled to capture a wide range of clinically relevant genomic alterations. This includes everything from single nucleotide variants and small insertions/deletions to more complex features such as microsatellite instability (MSI), tumor mutational burden (TMB), copy number variations (CNVs), gene rearrangements, and homologous recombination deficiency (HRD). With this level of detail, you can clearly understand the molecular characteristics of each sample before starting your work.

All sequencing is carried out in certified laboratories using validated protocols. This ensures high-quality data, consistent variant detection, and results that align with real-world clinical and diagnostic expectations.

We provide both tumor-only specimens and matched tumor–normal pairs, along with pre-verified normal control tissues. These options support assay development, validation, and comparative studies with improved reliability and fewer variables.

Each sample comes with a structured clinical report summarizing key findings. In addition, raw sequencing files—such as FASTQ, BAM, and VCF—are available, giving you full access to review, validate, and analyze the data independently.

Our biospecimens are available in multiple formats, including FFPE tissues, fresh frozen samples, plasma, and matched multi-sample sets. This flexibility allows you to choose the right type of material for your specific research goals.

We believe in complete transparency—no unexpected fees or unclear deliverables. What you see is exactly what you get.

When working with us, you benefit from:

• Consistently high-quality, validated samples

• Clear, accessible data with no “black box” limitations

• Fast and dependable turnaround times to keep your research on track